DENOSUMAB (Prolia®)

Alert: see other clinical indications

Clinical Indication

Osteoporosis

Comments

Full SCA

Request form

Date of classification

May 2014

Review date

November 2016

Amber FULL SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.

Other Clinical Indications for This Drug

Drug Name Classification Clinical Indication Comments
DENOSUMAB (Xgeva®) Amber Full SCA Prevention of skeletal related events in adults with bone metastases from solid tumours other than prostate

Full SCA
DENOSUMAB (Xgeva®) Red Prevention of skeletal related events in adults with bone metastases from solid tumours other than prostate

Red for patients with severe renal impairment (creatinine clearance less than 30ml/min)